NIVF · NewGenIvf Group Ltd · Insider Trading

The Class B Ordinary Shares were acquired through the exercise of vested stock options ("Options"). The Options were granted pursuant to the Issuer's 2024 Share Incentive Plan and the employee share option agreements, dated July 8, 2026 and August 17, 2026, between the Issuer and the Reporting Person (the "Option Agreements"). The options were exercised by the Reporting Person on October 5, 2026.

The share amounts reported herein have been adjusted to reflect two 1-for-3 reverse-stock-splits implemented by the Issuer on July 6, 2026 and September 1, 2026. The amount of securities beneficially owned following the reported transaction reflects: (i) 139,811 Class B Ordinary Shares issued under this exercise, and (ii) 6,322 Class B Ordinary Shares historically held (adjusted from the 56,890 pre-reverse-split shares previously reported).

The Class B Ordinary Shares were acquired through the exercise of vested stock options ("Options"). The Options were granted pursuant to the Issuer's 2024 Share Incentive Plan and the employee share option agreement, dated July 8, 2026 and August 17, 2026, between the Issuer and the Reporting Person (the "Option Agreement"). The options were exercised by the Reporting Person on October 5, 2026.

The share amounts reported herein have been adjusted to reflect two 1-for-3 reverse-stock-splits implemented by the Issuer on July 6, 2026 and September 1, 2026. The amount of securities beneficially owned following the reported transaction reflects: (i) 139,811 Class B Ordinary Shares issued under this exercise, and (ii) 6,321 Class B Ordinary Shares historically held (adjusted from the 56,881 pre-reverse-split shares previously reported).

Reflects the grant of stock options to acquire 272,140 Class B Ordinary Shares of the Issuer at an exercise price of US$0.0001 per share, made pursuant to the Issuer's 2024 Share Incentive Plan and the Employee Stock Option Agreement, dated August 17, 2026, between the Issuer and the Reporting Person (the "Option Agreement"). The options vest upon grant and expire on August 17, 2033 (Grant Date + 7 years), subject to earlier termination as provided in the Option Agreement and the Plan.

Reflects the grant of stock options to acquire 272,140 Class B Ordinary Shares of the Issuer at an exercise price of US$0.0001 per share, made pursuant to the Issuer's 2024 Share Incentive Plan and the Employee Stock Option Agreement, dated August 17, 2026, between the Issuer and the Reporting Person (the "Option Agreement"). The options vest upon grant and expire on August 17, 2033 (Grant Date + 7 years), subject to earlier termination as provided in the Option Agreement and the Plan.

The Class A ordinary shares reported herein reflect Class A ordinary shares issued directly to the Reporting Person (as the "Seller") pursuant to the terms of certain share purchase agreements by and among the Issuer (as the "Buyer") and the Reporting Person. The share amounts reported in tranches (i) through (iii) have been adjusted to reflect a 1-for-3 reverse stock split: (i) 222,223 Class A ordinary shares (adjusted from 666,667 pre-split shares) issued under the Share Purchase Agreement dated May 28, 2026; (ii) 500,000 Class A ordinary shares (adjusted from 1,500,000 pre-split shares) issued under the Share Purchase Agreement dated June 2, 2026; (iii) 500,000 Class A ordinary shares (adjusted from 1,500,000 pre-split shares) issued under the Share Purchase Agreement dated June 18, 2026; and (iv) 2,500,000 Class A ordinary shares issued under the Share Purchase Agreement dated July 27, 2026.

The Employee Share Options were granted pursuant to the Issuer's 2024 Share Incentive Plan and an employee share option agreement, dated July 8, 2026, between the Issuer and the Reporting Person (the "Option Agreement").

The Employee Share Options vest monthly, over 36 months, with the first tranche of 10% vesting on August 8, 2026. Thereafter, the Employee Share Options vest monthly in tranches of approximately 2.6%.

The Employee Share Options were granted pursuant to the Issuer's 2024 Share Incentive Plan and an employee share option agreement, dated July 8, 2026, between the Issuer and the Reporting Person (the "Option Agreement").

The Employee Share Options vest monthly, over 36 months, with the first tranche of 10% vesting on August 8, 2026. Thereafter, the Employee Share Options vest monthly in tranches of approximately 2.6%.

The Class A ordinary shares reported herein reflect Class A ordinary shares issued directly to the Reporting Person (as the "Seller") pursuant to the terms of certain share purchase agreements by and among the Issuer (as the "Buyer") and the Reporting Person. The share amounts reported in tranches (i) through (iii) have been adjusted to reflect a 1-for-3 reverse stock split: (i) 222,223 Class A ordinary shares (adjusted from 666,667 pre-split shares) issued under the Share Purchase Agreement dated May 28, 2026; (ii) 500,000 Class A ordinary shares (adjusted from 1,500,000 pre-split shares) issued under the Share Purchase Agreement dated June 2, 2026; (iii) 500,000 Class A ordinary shares (adjusted from 1,500,000 pre-split shares) issued under the Share Purchase Agreement dated June 18, 2026; and (iv) 2,500,000 Class A ordinary shares issued under the Share Purchase Agreement dated July 27, 2026.

The Class B Ordinary Shares were acquired through the exercise of vested stock options ("Options"). The Options were granted pursuant to the Issuer's 2024 Share Incentive Plan and the employee share option agreement, dated 4 May 2026, between the Issuer and the Reporting Person (the "Option Agreement"). The options were accelerated by resolution of the independent directors of the Board of Directors on 26 May 2026, and were exercised by the Reporting Person on 4 June 2026.

The Class B Ordinary Shares were acquired through the exercise of vested stock options ("Options"). The Options were granted pursuant to the Issuer's 2024 Share Incentive Plan and the employee share option agreement, dated 4 May 2026, between the Issuer and the Reporting Person (the "Option Agreement"). The options were accelerated by resolution of the independent directors of the Board of Directors on 26 May 2026, and were exercised by the Reporting Person on 4 June 2026.

The Class A ordinary shares reported herein reflect Class A ordinary shares issued directly to the Reporting Person (as the "Seller") pursuant to the terms of certain share purchase agreements by and among the Issuer (as the "Buyer") and the Reporting Person. The share amounts reported in tranches (i) through (iii) have been adjusted to reflect a 1-for-3 reverse stock split: (i) 222,223 Class A ordinary shares (adjusted from 666,667 pre-split shares) issued under the Share Purchase Agreement dated May 28, 2026; (ii) 500,000 Class A ordinary shares (adjusted from 1,500,000 pre-split shares) issued under the Share Purchase Agreement dated June 2, 2026; (iii) 500,000 Class A ordinary shares (adjusted from 1,500,000 pre-split shares) issued under the Share Purchase Agreement dated June 18, 2026; and (iv) 2,500,000 Class A ordinary shares issued under the Share Purchase Agreement dated July 27, 2026.

The Class A ordinary shares reported herein reflect Class A ordinary shares issued directly to the Reporting Person (as the "Seller") pursuant to the terms of certain share purchase agreements by and among the Issuer (as the "Buyer") and the Reporting Person. The share amounts reported in tranches (i) through (iii) have been adjusted to reflect a 1-for-3 reverse stock split: (i) 222,223 Class A ordinary shares (adjusted from 666,667 pre-split shares) issued under the Share Purchase Agreement dated May 28, 2026; (ii) 500,000 Class A ordinary shares (adjusted from 1,500,000 pre-split shares) issued under the Share Purchase Agreement dated June 2, 2026; (iii) 500,000 Class A ordinary shares (adjusted from 1,500,000 pre-split shares) issued under the Share Purchase Agreement dated June 18, 2026; and (iv) 2,500,000 Class A ordinary shares issued under the Share Purchase Agreement dated July 27, 2026.

Reflects the grant of stock options to acquire 56,851 Class B Ordinary Shares of the Issuer at an exercise price of US$0.0001 per share, made pursuant to the Issuer's 2024 Share Incentive Plan and the Employee Stock Option Agreement, dated 4 May 2026, between the Issuer and the Reporting Person (the "Option Agreement"). The options vest as follows: 5,685 options on 4 June 2026 (First Tranche); 1,462 options on the 4th day of each month from 4 July 2026 through 4 April 2029 (34 monthly tranches); and 1,458 options on 4 May 2029 (Final Tranche). The options expire on 4 May 2033, subject to earlier termination as provided in the Option Agreement and the Plan.

Reflects the grant of stock options to acquire 56,851 Class B Ordinary Shares of the Issuer at an exercise price of US$0.0001 per share, made pursuant to the Issuer's 2024 Share Incentive Plan and the Employee Stock Option Agreement, dated 4 May 2026, between the Issuer and the Reporting Person (the "Option Agreement"). The options vest as follows: 5,685 options on 4 June 2026 (First Tranche); 1,462 options on the 4th day of each month from 4 July 2026 through 4 April 2029 (34 monthly tranches); and 1,458 options on 4 May 2029 (Final Tranche). The options expire on 4 May 2033, subject to earlier termination as provided in the Option Agreement and the Plan.